CG Invites Co., Ltd. — Investor Relations & Filings
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 전환사채(해외전환사채포함)발행후만기전사채취득(제12회차) | 2022-08-08 | Korean | |
| 소송등의판결ㆍ결정(신주발행금지가처분) | 2022-08-05 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2022-08-05 | Korean | |
| 주요사항보고서(소송등의제기) | 2022-08-03 | Korean | |
| 주요사항보고서(소송등의제기) | 2022-08-02 | Korean | |
| 주요사항보고서(유상증자결정) | 2022-07-29 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 8647182 | 전환사채(해외전환사채포함)발행후만기전사채취득(제12회차) | 2022-08-08 | Korean | ||
| 8647537 | 소송등의판결ㆍ결정(신주발행금지가처분) | 2022-08-05 | Korean | ||
| 8647533 | [기재정정]주요사항보고서(유상증자결정) | 2022-08-05 | Korean | ||
| 8648744 | 주요사항보고서(소송등의제기) | 2022-08-03 | Korean | ||
| 8649178 | 주요사항보고서(소송등의제기) | 2022-08-02 | Korean | ||
| 8650230 | 주요사항보고서(유상증자결정) | 2022-07-29 | Korean | ||
| 8666197 | 투자판단관련주요경영사항(임상 2상 시험계획 조기 종료 신청) | 2022-07-01 | Korean | ||
| 8669260 | 주식등의대량보유상황보고서(약식) | 2022-06-27 | Korean | ||
| 8669915 | 증권발행결과(자율공시)(제3자배정-상환전환우선주) | 2022-06-24 | Korean | ||
| 8675350 | 주요사항보고서(유상증자결정) | 2022-06-14 | Korean | ||
| 8693174 | 신탁계약해지결과보고서 | 2022-05-16 | Korean | ||
| 8692290 | 분기보고서 (2022.03) | 2022-05-16 | Korean | ||
| 8736340 | [기재정정]사업보고서 (2021.12) | 2022-03-29 | Korean | ||
| 8738971 | 정기주주총회결과 | 2022-03-28 | Korean | ||
| 8753575 | 투자판단관련주요경영사항(신종코로나-19 바이러스 감염이 확진된 입원을 요하는 중등증 및 중증 COVID-19 환자에서 Ivaltinostat 치료 유효성 및 안전성 평가를 위한 국내2상 임상시험계획 자진 취하 신청) | 2022-03-21 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CG Invites Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17283/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17283 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17283 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17283 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17283}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CG Invites Co., Ltd. (id: 17283)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.